Saltar al contenido
Merck

Documentos clave

Ver Toda la documentación

Saltar a

W109

S(–)-WIN 55,212-3 mesylate salt

solid

Sinónimos:

S(–)-[2,3-Dihydro-5-methyl-3-[(4-morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate salt

Iniciar sesión para ver los precios por organización y contrato.

Acerca de este artículo

Fórmula lineal:
C27H26N2O3 · CH3SO3H
Número CAS:
131543-25-4
Peso molecular:
522.61
UNSPSC Code:
12352200
PubChem Substance ID:
24900777
MDL number:
MFCD00467944

form

solid

optical activity

[α]/D −48.0°, c = 0.246 in DMSO(lit.)

drug control

regulated under CDSA - not available from Sigma-Aldrich Canada

color

off-white

solubility

45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 2.4 mg/mL, DMSO: soluble, methanol: soluble

SMILES string

CS(O)(=O)=O.Cc1c(C(=O)c2cccc3ccccc23)c4cccc5OC[C@H](CN6CCOCC6)n1c45

Biochem/physiol Actions

Inactive enantiomer of WIN 55,212-2.

Legal Information

Manufactured and sold with the permission of Sterling Winthrop.

Disclaimer

Hygroscopic

Clase de almacenamiento

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number
026K4622
110K4609

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

Busque por un COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

U Herzberg et al.
Neuroscience letters, 221(2-3), 157-160 (1997-01-17)
The effects of a high affinity cannabinoid receptor agonist were evaluated in rats subjected to chronic constriction injury of the sciatic nerve (CCI) or a sham operation. Intraperitoneal (i.p.) injections of the active, but not the inactive enantiomer, alleviated the
X Pan et al.
Molecular pharmacology, 49(4), 707-714 (1996-04-01)
Modulation of neuronal ion channels by the cloned rat brain CB1 cannabinoid receptor was investigated with the use of a heterologous neuronal expression system. Transient expression of the rat brain CB1 cannabinoid receptor was accomplished through microinjection of in vitro
A Richter et al.
European journal of pharmacology, 264(3), 371-377 (1994-11-03)
The effects of the novel high affinity cannabinoid receptor agonist (+)-WIN 55,212-2 ((R)-4,5-dihydro-2-methyl-4(4-morphoinylmethyl)-1-(1-naphthalen ylcarbonyl)-6H-pyrrolo[3,2,1-ij]quinolin-6-one) on severity of dystonia were investigated in mutant Syrian hamsters with primary generalized dystonia. Following injections of (+)-WIN 55,212-2 (1.0-5.0 mg/kg i.p.) a dose-dependent reduction of